Spectral Medical, Inc. (EDT.TO)
1.40
+0.01
(+0.72%)
CAD |
TSX |
Jan 08, 15:59
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 404.79M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 143.9% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 147.52 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -0.3016 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 83.33% |
Profile
| Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include endotoxin activity assay diagnostic and polymyxin b-hemoperfusion therapeutic device. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada. |
| URL | http://www.spectraldx.com |
| Investor Relations URL | https://spectraldx.com/investors/ |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | Mar. 22, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include endotoxin activity assay diagnostic and polymyxin b-hemoperfusion therapeutic device. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada. |
| URL | http://www.spectraldx.com |
| Investor Relations URL | https://spectraldx.com/investors/ |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | Mar. 22, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |